Abstract
The serum globulin separated from the normal human blood collected by the American Red Cross has been used in studies on the treatment of measles in its early stages. Fraction II +III was used in 8 cases and Fraction II in 53 cases. Dosages ranged from 5-35 ml and ages from 10 mos. to 34 yrs. Of 30 individuals injected after the rash had started, there appeared to be modification of the disease in 13. Of 31 individuals injected when Koplik spots were present but no rash, there appeared to be modification of the disease in 24. In 2 of these individuals, no rash developed.